Andres Camacho-Gonzalez
- SOM: Peds: Infectious Disease
Associate Professor
- (404) 727-4664
- acamac2@emory.edu
-
Emory University
Pediatric Infectious Diseases
2015 Uppergate Drive
Academic Appointment
- Associate Professor of Pediatrics, Division of Pediatric Infectious Diseases, Emory University School of Medicine
Education
Degrees
- MSc from Emory University/ Laney Graduate School
- MD from Universidad del Rosario School of Medicine
Research
Publications
-
Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers.
Vaccines (Basel) Volume: 13
02/01/2025 Authors: Hatabah D; Gupta SL; Mantus G; Sullivan P; Heilman S; Camacho-Gonzalez A; Leake D; Le M; Griffiths M; Norwood C -
Corrigendum to "Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study" [Internation Journal of Infectious Diseases, volume 144 (2024) 107064].
Int J Infect Dis Volume: 149 Page(s): 107278
12/01/2024 Authors: Griffiths M; Hatabah D; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Heilman S; Camacho-Gonzalez A; Leake D; Korman R -
Incidence of SARS-CoV-2 seropositivity in pediatric healthcare workers prior to widespread vaccination: A 5-month longitudinal cohort study.
Int J Infect Dis Volume: 144 Page(s): 107064
07/01/2024 Authors: Griffiths M; Hatabah D; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Heilman S; Camacho-Gonzalez A; Leake D; Korman R -
Incidence of Sexually Transmitted Infections in Youth with HIV During Pre-COVID and COVID Era.
AIDS Patient Care STDS Volume: 38 Page(s): 252 - 258
06/01/2024 Authors: Khan F; Loerinc LB; Scheel A; Gillespie SE; Camacho-Gonzalez AF -
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.
Lancet HIV Volume: 11 Page(s): e211 - e221
04/01/2024 Authors: Gaur AH; Capparelli EV; Calabrese K; Baltrusaitis K; Marzinke MA; McCoig C; Van Solingen-Ristea RM; Mathiba SR; Adeyeye A; Moye JH -
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.
Lancet HIV Volume: 11 Page(s): e222 - e232
04/01/2024 Authors: Lowenthal ED; Chapman J; Ohrenschall R; Calabrese K; Baltrusaitis K; Heckman B; Yin DE; Agwu AL; Harrington C; Van Solingen-Ristea RM -
Risk of COVID-19 after natural infection or vaccination.
EBioMedicine Volume: 96 Page(s): 104799
10/01/2023 Authors: Rick A-M; Laurens MB; Huang Y; Yu C; Martin TCS; Rodriguez CA; Rostad CA; Maboa RM; Baden LR; El Sahly HM -
HIV in youth prevention in the emergency department initiative: A survey of pediatric emergency medicine providers.
Am J Emerg Med Volume: 72 Page(s): 164 - 169
10/01/2023 Authors: Labudde EJ; Gillespie S; Wood A; Middlebrooks L; Gooding HC; Morris CR; Camacho-Gonzalez A -
Human Immunodeficiency Virus (HIV) Care Continuum Outcomes After Transition to Adult Care Among a Prospective Cohort of Youth With HIV in Atlanta, Georgia.
Clin Infect Dis Volume: 76 Page(s): 1218 - 1224
04/03/2023 Authors: Hussen SA; Doraivelu K; Goldstein MH; Shenvi N; Easley KA; Zanoni BC; Camacho-Gonzlez A; Del Ro C -
ILLUMINATING PERCEPTIONS SURROUNDING CONDOM USE IN YOUNG MEN WHO HAVE SEX WITH MEN LIVING WITH HIV IN ATLANTA, GA
Volume: 72 Page(s): S36 - S37
03/01/2023 Authors: Castellano C; Loerinc L; Khan F; Cleary P; White M; McCool-Myers M; Camacho-Gonzalez A